Elevation of plasma eotaxin levels in children with food allergy

Japanese Journal of Clinical Immunology

Volumn 32, Issue 3, 2009, Pages 180-185

  Matsuura, Hiroki ^a,b   Ishiguro, Akira ^a   Abe, Hiroyuki ^a   Mamada, Yoko ^a   Suzuki, Tetsuomi ^a   Kohda, Kyoko ^a   Shimbo, Toshikazu ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Eosinophil; Eotaxin; Food allergy; Immunoglobulin E

Indexed keywords

EOTAXIN; EOTAXIN 3; IMMUNOGLOBULIN E;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FOOD ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL;

CHEMOKINE CCL11; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FOOD HYPERSENSITIVITY; HUMANS; INFANT;

EID: 77953672013     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.32.180     Document Type: Article

References (25)

1. Greener M.: Dissecting the molecular basis of food allergy. Mol Med Today. 6: 336, 2000.
2. Frew AJ.:The immunology ofrespiratory allergies. Toxicol Lett. 86: 65-72, 1996.
3. Piliponsky AM. et al.: Non-IgE-dependent activation of human lung-and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood. 101: 1898-1904, 2003.
4. Drazen JM. et al.: Sorting out the cytokines of asthma. J Exp Med. 183: 1-5, 1996.
5. Broide D, Sriramarao P.: Eosinophil trafficking to sites of allergic inflammation. Immunol Rev. 179: 163-172, 2001.
6. Shinkai A, et al.: A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol. 163: 1602-1610, 1999.
7. Ponath PD. et al.: Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest. 97: 604-612, 1996.
8. Kitaura M. et al.: Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem. 271: 7725-7730. 1996.
9. Ponath PD. et al.: Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med. 183: 2437-2448, 1996.
10. Uguccioni M. et al.: High expression of the chemokine receptor CCR3 in human blood basophils. Role inactivation by eotaxin, MCP-4, and other chemokines. J Clin Invest. 100: 1137-1143, 1997.
11. Sallusto F. et al.: Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277: 2005-2007, 1997.
12. Hossny E. et al.: Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Allergy. 56: 996-1002, 2001.
13. Lilly CM et al.: Elevated plasma eotaxin levels in patients with acute asthma. J Allergy Clin Immunol. 104: 786-790, 1999.
14. AT Clark, et al.: Food allergy in childhood. Arch Dis Child. 88(1): 79-81, 2003.
15. Lamkhioued B. et al.: Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol. 159: 4593-4601, 1997.
16. Yamada H. et al.: Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum. Allergy. 55: 392-397, 2000.
17. Taha RA. et al.: Increased expression of the chemoattractant cytokines eotaxin, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients. Chest. 120: 595-601, 2001.
18. Bottcher MF. et al.: Chemoattractant factors in breast milk from allergic and nonallergic mothers. Pediatr Res. 47: 592-597, 2000.
19. Taha RA. et al.: Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol. 105: 1002-1007, 2000.
20. Fulkerson PC. et al.: A central regulatory role for eosinophils and the eotaxin-CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci USA. 103: 16418-16423, 2006.
21. Leung TF, et al.: Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol. 14: 296-301, 2003.
22. Jahnz-Rozyk K, et al.: Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy. 60: 685-688, 2005.
23. Berkman N, et al.: Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 hours after allergen challenge. Am J Respir Cell Mol Biol. 24: 682-687, 2001.
24. Kagami S, et al.: Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol. 134: 309-313, 2003.
25. Polzer K, et al.: Eotaxin-3 is involved in Churg-Strauss syndrome -a serum marker closely correlating with disease activity. Rheumatology. 47: 804-808, 2008.